| Variables | All () | OAC alone () | OAC+antiplatelet () | Antiplatelet alone () | value |
| Age (years) | | | | | 0.018c | Female gender | 1,322 (42.3%) | 1,017 (45.0%) | 97 (31.5%) | 218 (37.5%) | <0.001a,b | Time after AF diagnosis (yrs) | | | | | 0.159 | Atrial fibrillation | | | | | <0.001a,b | (i) Paroxysmal | 998 (31.7%) | 657 (29.1%) | 121 (39.3%) | 220 (37.8%) | | (ii) Persistent | 603 (19.2%) | 406 (18.0%) | 75 (24.4%) | 122 (21.0%) | | (iii) Permanent | 1,547 (49.1%) | 1,195 (52.9%) | 112 (36.4%) | 240 (41.2%) | | Symptomatic AF | 2,421 (76.9%) | 1,751 (77.5%) | 222 (72.1%) | 448 (77.0%) | 0.102 | History of heart failure | 866 (27.5%) | 578 (25.6%) | 123 (39.9%) | 165 (28.4%) | <0.001a,c | History of CAD | 540 (17.2%) | 227 (10.1%) | 189 (61.4%) | 124 (21.3%) | <0.001a,b,c | CIED | 323 (10.3%) | 224 (9.9%) | 46 (14.9%) | 53 (9.1%) | 0.015a,c | History of ischemic stroke/TIA | 578 (18.4%) | 477 (21.1%) | 61 (19.8%) | 40 (6.9%) | <0.001b,c | Hypertension | 2,232 (70.9%) | 1,619 (71.7%) | 242 (78.6%) | 371 (63.7%) | <0.001a,b,c | Diabetes mellitus | 819 (26.0%) | 564 (25.0%) | 126 (40.9%) | 129 (22.2%) | <0.001a,c | Smoking | 618 (19.6%) | 383 (17.0%) | 90 (29.2%) | 145 (24.9%) | <0.001a,b | Dyslipidemia | 1,822 (57.9%) | 1,278 (56.6%) | 228 (74.0%) | 316 (54.3%) | <0.001a,c | Renal replacement therapy | 38 (1.2%) | 14 (0.6%) | 8 (2.6%) | 16 (2.7%) | <0.001a,b | Dementia | 29 (0.9%) | 19 (0.8%) | 6 (1.9%) | 4 (0.7%) | 0.131 | History of bleeding | 308 (9.8%) | 225 (10.0%) | 47 (15.3%) | 36 (6.2%) | <0.001a,b,c | History of PAD | 41 (1.3%) | 20 (0.9%) | 12 (3.9%) | 9 (1.5%) | <0.001a | CHA2DS2-VASc score | | | | | <0.001a,b,c | (i) 0 | 108 (3.4%) | 60 (2.7%) | 1 (0.3%) | 47 (8.1%) | | (ii) 1 | 357 (11.3%) | 215 (9.5%) | 21 (6.8%) | 121 (20.8%) | | (iii) ≥2 | 2,683 (85.2%) | 1,983 (87.8%) | 286 (92.9%) | 414 (71.1%) | | HAS-BLED score | | | | | <0.001a,b,c | (i) 0 | 344 (10.9%) | 334 (14.8%) | 2 (0.6%) | 8 (1.4%) | | (ii) 1-2 | 2,276 (72.3%) | 1,657 (73.4%) | 160 (51.9%) | 459 (78.9%) | | (iii) ≥3 | 528 (16.8%) | 267 (11.8%) | 146 (47.4%) | 115 (19.8%) | |
|
|